Bay Pines VA Healthcare System
Cooperative Research and Development Agreement (CRADA)
The CRADA is one of the principal mechanisms used by federal labs to engage in collaborative efforts with non-federal partners to achieve goals of technology transfer. It is intended to be a flexible mechanism that can be adapted to a variety of types of collaborative efforts between federal and non-federal organizations and that can be implemented relatively easily within a relatively short time. As a technology transfer mechanism, the CRADA is an extremely useful tool in moving federally funded R&D into the private sector.
The following list is companies with whom we have negotiated a CRADA at Bay Pines.
- 3M Company
- Advanced BioHealing, Incorporated
- Aesculap, Inc.
- Amgen, Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Genentech, Inc.
- Healthpoint, Ltd.
- Integra LifeSciences Corporation
- Market Strategies International
- Pfizer, Inc.
- Romark Laboratories, L.C.
- Stemnion, Inc.
- Synta Pharmaceuticals Corp